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Abstract 
Background: Deficits in the sensorimotor system and its peripheral and central 
processing of the affected body part might be a contributing factor to chronic low 
back pain (CLBP). Hence, sensorimotor assessment is important. Valid and reliable 
sensorimotor measurement instruments are needed. 
Objective: To investigate the reliability and validity of sensorimotor measurement 
instruments for people with chronic low back pain (CLBP). 
Design: Systematic review and meta-analysis. 
Methods: The review was undertaken using the COSMIN guidelines. Databases 
were searched for studies investigating the clinimetric properties of sensorimotor 
tests in people with CLBP. The methodological study quality was rated by two 
independent reviewers using the COSMIN 4-point rating checklist.  
Results: Ten studies were included covering six sensorimotor measurement 
instruments with findings for reliability/measurement error, known-groups validity and 
convergent validity. The methodological quality ranged from poor to good, 
with only one study rated as good. There was insufficient evidence of enough quality 
to assess reliability/measurement error or convergent validity. Two-point 
discrimination, laterality judgement and movement control tests had moderate 
evidence supporting their ability to distinguish between healthy people and those with 
CLBP. 
Conclusions: Two-point discrimination, laterality judgment and movement control 
tests demonstrate the greatest level of known-groups validity for people with CLBP. 
However, as the reliability of these measurement tools have yet to be established, 
this validity data should be interpreted cautiously. Further research is warranted to 
investigate the clinimetric properties of these sensorimotor techniques. 
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Introduction 
Chronic low back pain (CLBP) is a major public health problem, with a lifetime 
prevalence of ~84% (Denteneer et al., 2016, Murray et al., 2013). It is a leading 
cause of disability worldwide (Murray et al., 2013).  Many factors contribute to the 
development and/or maintenance of CLBP (Denteneer et al., 2016). It has been 
proposed that deficits in the sensorimotor system (sensorimotor dysfunction) could 
be a contributing factor (Apkarian et al., 2011, Catley et al., 2014, Moseley and Flor, 
2012). As such, there is growing interest in outcome measures and interventions that 
attempt to measure and improve sensorimotor function in people with CLBP 
(Ehrenbrusthoff et al., 2016, Elgueta-Cancino et al., 2015, Louw et al., 2015, Louw et 
al., 2016, Villafane et al., 2015, Vuilleumier et al., 2015). 
 
Sensorimotor function  encompasses all sensory and motor elements necessary for 
an individual to interact with their environment (Shumway-Cook and Woollacott, 
2007). This includes the output from the nervous system contributing to motor 
function and any sensory input contributing to the interpretation of body position and 
movement (Hodges and Falla, 2015). A range of sensorimotor measurement 
instruments (SMIs) exist that attempt to measure the construct of sensorimotor 
dysfunction, defined as a process of altered motor behavior, and/or distorted 
interpretation or inaccurate input of afferent sensory information (Hodges and Falla, 
2015, Pelletier et al., 2015). Some SMIs require expensive specialist equipment and 
highly skilled technical staff, such as functional magnetic resonance imaging (fMRI). 
Such techniques are beyond the capacity of routine clinical practice. Thus, there is a 
need for simple SMIs that are clinically practicable, to facilitate sensorimotor 
assessment and intervention.  
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There are a number of clinically practicable SMIs, such as two-point discrimination 
(TPD), laterality judgement and movement control tests (MCTs) (Catley et al., 2013, 
Luomajoki, 2012, Moseley, 2006). An essential prerequisite for any clinical test is that 
it demonstrates sound clinimetric properties (De Vet et al., 2011), particularly, 
reliability and validity (Atkinson and Nevill, 1998, De Vet et al., 2011). The clinimetric 
properties of some SMIs have been investigated in healthy people and an array of 
patient groups (Auld et al., 2011, Stanton et al., 2013, Wand et al., 2014a). The 
clinimetric properties of some of these SMIs have been explored in people with CLBP 
but the extent and the quality of the work has not been systematically reviewed. Such 
a review is needed to guide research and clinical practice in the field. Thus, the aim 
of this study was to systematically investigate the reliability and validity of simple 
SMIs in people with CLBP. 
 
Methods 
The search strategy was developed in accordance with COSMIN recommendations 
(Terwee et al., 2011) and the PRISMA guidelines (Moher et al., 2010).  This 
systematic review is registered on PROSPERO (Registration number: 
CRD42015026880).  
Structured search strategies were designed using search terms appropriate for each 
database. Standardised database subject headings such as MeSH terms (in 
MEDLINE) and Subject Headings (in CINAHL) were used in each database, as 
appropriate. For the MEDLINE search, the sensitive PubMed search filter proposed 
by COSMIN for measurement properties was used (Terwee et al., 2009). Search 
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terms and synonyms were searched separately in four main categories and finally 
combined into one search string per database. The categories complied with 
COSMIN guidelines (Terwee et al., 2009) and were defined as: 
1. Construct: tactile acuity OR sensorimotor dysfunction OR cortical reorganization 
2. Target population: chronic low back pain 
3. Measurement instrument: sensorimotor test 
4. Measurement properties: sensitive COSMIN search filter for measurement 
properties for in MEDLINE  
Electronic searches of databases were conducted by one author (K.E.) until March 
30th 2015 using MEDLINE via PubMed, CINAHL via EBSCO, Embase via Ovid and 
Central via Wiley. The search was updated with a time restriction from March 30th 
2015 to April 30th 2016 to identify relevant studies published ad interim. A full 
description of the search strategies can be found in the supplementary data 
(Appendix 1: Search strategies for all databases). Identified records were screened 
by K.E. by title-abstract initially and then by full-text screening. Hand searching of key 
reference lists was also conducted. 
 
Eligibility Criteria 
Studies were included if: 1) their target population were individuals with CLBP, 
defined as pain between the 12th rib and the buttock creases, persisting for 3 months 
(Savigny et al., 2009),  2) the SMI investigated claimed to measure a component of 
sensorimotor dysfunction, 3) the SMI investigated was practicable without 
sophisticated/expensive instrumentation (e.g. an functional Magnetic Resonance 
Imaging (fMRI) machine) not easily accessible in a routine clinical setting. An 
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example of an unsophisticated and inexpensive piece of equipment would be a 
goniometer,  4) the aim was to investigate one or more measurement properties of 
the SMI under investigation, 5)  they were designed to investigate reliability or validity 
of the SMI, in accordance with the COSMIN taxonomy (Mokkink et al., 2009), 6) the 
study was published as a full original article in English or German. 
Studies were excluded if: 1) they were of an intervention based or single-case 
design, 2) the SMI investigated required extensive technical skills and/or equipment 
not found in routine clinical practice (e.g. fMRI, motion analysis systems). 
 
Data Extraction 
According to the COSMIN recommendations for data extraction, the generalisability 
box of the COSMIN tool was used to extract data on characteristics of the study 
sample (median/mean age, distribution of sex, important disease characteristics, 
setting, country, language, sampling strategy, percentage of missing responses). In 
addition, details of each SMI data collection protocol were summarised and the 
measurement property results per SMI were extracted separately (De Vet et al. 
2011). The extraction process was carried out by the lead author (K.E). 
 
Methodological Quality Evaluation 
The COSMIN four-point scoring checklist (Terwee et al., 2012) was used to assess 
the methodological quality of included studies. The checklist is a validated  tool 
comprising 10 sections, each assessing a separate measurement property (Mokkink 
et al., 2010a, Mokkink et al., 2010b).Two reviewers (C.R. and K.E.) with prior 
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experience in using the checklist rated each study. Each item for methodological 
quality within each section was scored from excellent to poor. The overall score for 
the measurement property within the study was defined as the lowest rating among 
all response options within one section, termed as “worst score counts” (Terwee et 
al., 2012). Where multiple measurement properties were assessed within one study, 
this study received multiple methodological quality evaluations. 
 
Evaluation of measurement properties 
In the studies included in the review, the results for each SMI measurement property 
were evaluated against the pre-defined quality for good measurement properties 
(Terwee et al., 2007), (see table 1 for details). For validity, we investigated the 
construct validity sub-categories known-groups validity and convergent validity. 
Known groups validity was defined as an instrument’s ability to discriminate between 
people with and without the target condition or between people having different 
manifestations of the target condition, respectively (De Vet et al., 2011). Convergent 
validity was defined as the expected relationship between instruments measuring 
related constructs (De Vet et al., 2011). 
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Table 1: Quality criteria for measurement properties 
Property Rating  Quality Criteria 
Reliability   
Internal 
consistency 
+ Cronbach’s alpha(s) ≥ 0.70 
? Cronbach’s alpha not determined or dimensionally 
unknown 
- Cronbach’s alpha(s) < 0.70 
Reliability + ICC / weighted Kappa ≥ 0.70 OR Pearson’s r ≥ 0.80 
? Neither ICC / weighted Kappa, nor Pearson’s r 
determined 
- ICC / weighted Kappa < 0.70 OR Pearson’s r < 0.80 
Measurement error + MIC > SDC OR MIC outside the LOA 
? MIC not defined 
- MIC ≤ SDC OR MIC equals or inside LOA 
Validity   
Content validity  
+ 
All items are considered to be relevant for the 
construct to be measured, for the target population, 
and for the purpose of the measurement AND the 
questionnaire is considered to be comprehensive 
? Not enough information available 
 
- 
Not all items are considered to be relevant for the 
construct to be measured, for the target population, 
and for the purpose of the measurement OR the 
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questionnaire is considered not to be 
comprehensive 
Construct validity 
- Structural validity 
+ Factors should explain at least 50% of the variance 
? Explained variance not mentioned 
- Factors explain < 50% of the variance 
- Hypothesis 
testing 
 
+ 
Correlations with instruments measuring the same 
construct ≥ 0.50 OR at least 75% of the results are 
in accordance with the hypotheses AND correlations 
with related constructs are higher than with 
unrelated constructs 
? Solely correlations determined with unrelated 
constructs 
 
- 
Correlations with instruments measuring the same 
construct < 0.50 OR < 75% of the results are in 
accordance with the hypotheses AND correlations 
with related constructs are lower than with unrelated 
constructs 
Cross-cultural 
validity 
+ No differences in factor structure OR no important 
DIF between language versions 
? Multiple group factor analysis not applied AND DIF 
not assessed 
- Differences in factor structure OR important DIF 
between language versions 
Criterion validity  + Convincing arguments that gold standard is “gold” 
AND correlation with gold standard ≥ 0.70 
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? No convincing arguments that gold standard is 
“gold” 
- Correlation with gold standard < 0.70 
Responsiveness   
  
+ 
Correlation with changes on instruments measuring 
the same construct ≥ 0.50 OR at least 75% of the 
results are in accordance with the hypotheses OR 
AUC ≥ 0.70 AND correlations with changes in 
related constructs are higher than with unrelated 
constructs 
? Solely correlations determined with unrelated 
constructs  
 
- 
Correlation with changes on instruments measuring 
the same construct < 0.50 OR < 75% of the results 
are in accordance with the hypotheses OR AUC < 
0.70 AND correlations with changes in related 
constructs are lower than with unrelated constructs 
Legend: MIC = minimal important change, SDC = smallest detectable change,  
LOA = limits of agreement, ICC = intraclass correlation coefficient, DIF = differential 
item functioning, AUC = area under the curve, + = positive rating,? = indeterminate 
rating, - = negative rating 
Table taken  from COSMIN guidelines (Terwee et al., 2011)1. 
                                            
1 Reprinted from the Journal of Clinical Epidemiology 2007;, Terwee CB, Bot SDM, de Boer MR, van 
der Windt DAWM, Knol DL, Dekker J, Bouter LM, de Vet HCW. Quality criteria were proposed for 
measurement properties of health status questionnaires, 60:34-42., Copyright (2007), with permission 
from Elsevier 
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Data synthesis: meta-analysis and best evidence synthesis  
Where multiple studies with comparable study designs investigated the same SMI 
and measurement property, a meta-analysis was conducted.   For known-groups 
validity, mean scores and standard deviations from healthy and patient groups were 
pooled using the statistical package RevMan (Version 5) by means of forest plots 
(fixed effects model) to establish a pooled difference between groups. Heterogeneity 
was quantified using the I2 (Higgins et al., 2003). Following the COSMIN 
recommendations, studies with a poor methodological score were excluded from 
quantitative pooling (Mokkink et al., 2009). Where quantitative pooling was not 
appropriate, a ‘best evidence synthesis” approach was used, (see Table 2) (Guyatt et 
al., 2011, Schünemann et al., 2011).  
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Table 2: Level of Evidence for the quality of the measurement property 
Level Rating* Criteria 
strong +++ or --- Consistent findings in multiple 
studies of good 
methodological quality OR in one 
study of excellent 
methodological quality 
moderate ++ or -- Consistent findings in multiple 
studies of fair 
methodological quality OR in one 
study of good 
methodological quality 
limited + or - One study of fair methodological 
quality 
conflicting +/- Conflicting findings 
unknown ? Only studies of poor 
methodological quality 
Legend: * + = positive rating,? = indeterminate rating, - = negative rating 
Table taken from COSMIN guidelines (Terwee et al., 2011)2 
 
  
                                            
2 Reprinted from the Journal of Clinical Epidemiology 2007; Terwee CB, Bot SDM, de Boer MR, van 
der Windt DAWM, Knol DL, Dekker J, Bouter LM, de Vet HCW. Quality criteria were proposed for 
measurement properties of health status questionnaires, 60:34-42., Copyright (2007), with permission 
from Elsevier 
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Results 
Study Selection 
Initially, 4,285 studies were identified, of which 407 were excluded as duplicates and 
another 3,839 were excluded following title and abstract screening. Fifty studies were 
included for full-text assessment from which nine studies evaluating six SMIs were 
included. In the updated search, 686 studies were initially identified, however, only 
one additional relevant study was included in the final study list. Thus, in total, 10 
studies (Table 3) evaluating six SMIs were included (Figure 1), within which three 
measurement properties were investigated: reliability/measurement error, known-
groups validity, and convergent validity. Details for the data collection protocols for 
each study are summarised in supplementary data (Appendix 2: Individual study data 
collection protocols). 
The findings for each measurement property per SMI from the individual studies are 
quantified in supplementary data (Appendices 4-8).  
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Figure 1: Flow chart of literature search and study selection process.  
Literature search: 
MEDLINE (via PubMed) n =   660 
CENTRAL (via Wiley)      n =     72 
CINAHL (via EBSCO) n = 2,726 
EMBASE (via OVID) n =    827 
Total number 
n = 4,285 
After duplicate removal 
n = 3,878 
Included for full text screening 
n = 39 
+ 11 from reference lists 
n= 50 
Excluded based on 
title/abstract 
n = 3,839 
Excluded based on full text screening/exclusion criteria 
n = 41: 
• Duplicate:    n = 1 
• Not target measurement instrument: n = 24 
• Not target population:   n = 2 
• Not target study design:    n = 14  
Total number of studies 
n = 9 
Total number of instruments 
n = 6 
Total number of studies identified via Search Update: 
n = 1 
Total number of instruments 
 n =1  
Total number of studies included in the systematic review 
n = 10 
Total number of instruments 
 n = 6 
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Table 3: Generalisability Box: Characteristics of included studies 
  Patient Characteristics  
Author (Year) 
 
a) Instrument 
b) Measurement 
Property 
c) n 
a) Mean Age (SD) 
(years) 
b) Distribution of Sex 
a) Pain Severity Mean 
(SD) 
b) Disability Mean (SD) 
a) Setting 
b) Country 
c) Language 
d) Sampling 
e) %of missing responses 
Linder et al (2015) a) Laterality Judgement 
b) Known-Groups 
Validity 
c) CLBP: n=30 
HC:  n=30 
a) CLBP:  44.9 (11.0) 
HC:   43.3 (9.6) 
b) CLBP:  ♀  = 20 
  ♂ = 10 
HC:   ♀  = 20
  ♂ = 10 
 
a) VAS Scores:  
55.3 (17.8) 
b) ODI Scores:  
25.1 (13.1) 
a) PT clinics 
b) Sweden 
c) Swedish 
d) CLBP: consecutive 
HC: convenience 
e) n=1 in CLBP group 
Nishigami et al 
(2015) 
a) TPD 
BID 
b) Known-Groups 
Validity 
c) CLBP: n=42 
HC:  n=17 
a) CLBP normal BI:  
65.1 (11.2) 
 CLBP expanded BI: 
 56.7 (16.7) 
 CLBP shrink BI: 
 62.0 (12.4) 
HC:   
 63.4 ± 12.2 
c) CLBP:  ♀  = 26  
  ♂ = 16 
HC:   ♀  =   8 
  ♂ =   9 
 
a) VAS Scores normal BI: 
48.3 (21.8) 
VAS Scores expanded 
BI: 
42.5 (24.5) 
VAS Scores shrink BI: 
42.0 (23.5) 
b) RMDQ Scores normal 
BI: 
7.0 (2.4) 
RMDQ Scores 
expanded BI: 
6.2 (3.4) 
RMDQ shrink BI: 
6.8 (4.4) 
a) Orthopedic clinic 
b) Japan 
c) Japanese 
d) Not stated 
e) Not stated 
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  Patient Characteristics  
Author (Year) 
 
a) Instrument 
b) Measurement 
Property 
c) n 
a) Mean Age (SD) 
(years) 
b) Distribution of Sex 
a) Pain Severity Mean 
(SD) 
b) Disability Mean (SD) 
a) Setting 
b) Country 
c) Language 
d) Sampling 
e) %of missing responses 
 
Wand et al (2014) a) FreBAQ 
b) Known-Groups 
Validity 
c) CLBP: n=51 
HC:  n=51 
a) CLBP: 41.7 (14.0) 
HC:  38.7 (13.4) 
b) CLBP:  ♀  = 21 
  ♂ = 30 
 HC:   ♀  = 20
  ♂ = 31 
a) NRS Scores (0-100): 
48.2 (17.8) 
b) RMDQ Scores: 
10.1 (5.9) 
a) Community PT practice; 
Department of pain 
management , The Sir 
Charles Gairdner 
Hospital, Perth, Western 
Australia 
b) English 
c) CLBP: convenience 
 HC: convenience 
d) Not stated 
Bowering et al 
(2014) 
a) Laterality Judgement 
b) Known-Groups 
Validity 
c) Current back pain: 
n=117 
History of back pain: 
n= 462 
HC: 
n= 429  
a) Complete sample: 
37 (13) 
b) Complete sample: 
♀  = 684; ♂ = 324 
 
a) Not stated 
b) Not stated 
a) Online study 
b) Australia 
c) English 
d) Convenience (online) 
e) 181 datasets excluded  
Stanton et al 
(2013) 
a) TPD 
b) Known Groups-
Validity 
Convergent Validity 
c) CLBP: n=17 
HC:  n=18 
a) CLBP: 45 (14) 
HC:  41 (11) 
b) CLBP:  ♀  = 14 
  ♂ =  3 
HC:  ♀  = 11 
 ♂ =  7 
a) Not stated 
b) Physical component of 
SF-36 (0-30): 
19.7 (7.4) 
a) Royal North Shore 
Hospital, Sydney 
b) Australia 
c) English 
d) CLBP data from Bray 
and Moseley (2011) 
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  Patient Characteristics  
Author (Year) 
 
a) Instrument 
b) Measurement 
Property 
c) n 
a) Mean Age (SD) 
(years) 
b) Distribution of Sex 
a) Pain Severity Mean 
(SD) 
b) Disability Mean (SD) 
a) Setting 
b) Country 
c) Language 
d) Sampling 
e) %of missing responses 
HC: convenience 
e) Not stated 
Bray and Moseley 
(2011) 
a) Laterality Judgement 
b) Known-Groups 
Validity 
c) CLBP: n=21 
HC:  n=14 
a) CLBP: 44 (13) 
       HC:  43 ( 7) 
b) CLBP:  ♀  = 15; ♂ =  
6 
HC:  ♀  =  9; ♂ =   
5 
a) VAS Scores (0-100): 
37 (21) 
b) Not stated 
a) Private PT practice 
b) United Kingdom (ethical 
approval) 
c) English 
d) Convenience sample 
e) Not stated 
Luomajoki and 
Moseley (2011) 
a) TPD 
Movement Control 
Tests 
b) Known-Groups 
Validity 
c) CLBP: n=45 
HC:   n=45 
a) CLBP: 43 (15) 
 HC:  41 (10) 
b) CLBP:  ♀  = 25; ♂ = 
20 
HC:  ♀  = 25; ♂ = 
20 
a) Not stated 
b) RMDQ Scores: 
9 (5) 
a) Private PT practice 
b) Switzerland 
c) German 
d) Convenience 
e) Not stated 
Wand et al (2010) a) TPD 
Graphesthesia 
b) Known-Groups 
Validity 
c) CLBP: n=19 
HC:   n=19 
a) CLBP: 41 (12.5) 
 HC:  34 (12.1) 
b) CLBP:  ♀  = 11 
 ♂ =  8 
HC:  ♀  = 14 
  ♂ =  5 
a) NRS Scores (0-10) 
usual pain: 
3.9 (2.1) 
b) Physical component of 
SF-36 (0-30): 
21.8 (5.0) 
a) District General hospital, 
Perth, Western Australia 
b) Australia 
c) English 
d) CLBP: convenience 
HC: convenience 
e) 2 subjects with 
ambiguous pain scores 
and missing scores 
respectively, treated as 
missing values  
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  Patient Characteristics  
Author (Year) 
 
a) Instrument 
b) Measurement 
Property 
c) n 
a) Mean Age (SD) 
(years) 
b) Distribution of Sex 
a) Pain Severity Mean 
(SD) 
b) Disability Mean (SD) 
a) Setting 
b) Country 
c) Language 
d) Sampling 
e) %of missing responses 
Moseley (2008) a) TPD 
BID 
b) Known-Groups 
Validity 
c) CLBP: n=  6 
HC:  n=10 
a) CLBP: 43.83 (11.12) 
 HC:  not stated 
b) CLBP:  ♀  =  3 
 ♂ =  3 
HC:  ♀  =  5 
 ♂ =  5 
a) VAS Scores: 
47.2 (12.54) 
b) Not stated 
a) Not stated 
b) UK 
c) English 
d) Consecutive 
e) Not stated 
Luomajoki (2008)( a) Movement Control 
Tests 
b) Known-Groups 
Validity 
c) LBP: n=108 
HC: n= 102 
a) LBP: 41 (15) 
 HC:  37 (12) 
b) LBP:  ♀  = 72 
 ♂ = 36 
HC:  ♀  =  58 
 ♂ = 44 
a) Not stated 
b) RMDQ Scores: 
8(5) 
a) Outpatient PT clinics, 
Canton Aargau 
b) Switzerland 
c) German 
d) CLBP: consecutive 
HC: convenience 
e) Not stated 
Separate Patient Characteristics of Studies investigating Reliability (Subsamples of CLBP patients) 
Wand  et al (2014) a) FreBAQ 
b) Reliability 
c) CLBP: n= 26 
a) 42 (14) 
b) ♀  = 12; ♂ = 14 
a) Back Pain Intensity (0-
100): 
47.7 (14.4) 
b) RMDQ Scores: 
10.6 (6.0) 
a) Community PT practice 
b) Australia 
c) English 
d) Not stated 
e) N=1 did not return 
second questionnaire; 
handled as missing item 
Bray and Moseley 
(2011) 
a) Laterality Judgement 
b) Reliability 
c) CLBP: n=  5 
a) 46 (16) 
b) ♀  =  1; ♂ =  4 
a) VAS Scores: 
46 (23) 
b) ODI Scores: 
25.1 (13.1) 
a) Private PT practice 
b) UK 
c) English 
d) Convenience 
e) Not stated 
 22 
 
  Patient Characteristics  
Author (Year) 
 
a) Instrument 
b) Measurement 
Property 
c) n 
a) Mean Age (SD) 
(years) 
b) Distribution of Sex 
a) Pain Severity Mean 
(SD) 
b) Disability Mean (SD) 
a) Setting 
b) Country 
c) Language 
d) Sampling 
e) %of missing responses 
Linder et al (2015) a) Laterality Judgement 
b) Measurement Error 
Reliability 
c) CLBP: n= 30 
a) 44.9 (11) 
b) ♀  = 20; ♂ = 10 
a) VAS Scores: 
55.3 (17.8) 
b) ODI Scores: 
25.1 (13.1) 
a) PT clinics 
b) Sweden 
c) Swedish 
d) Convenience 
e) Not stated 
Legend: CLBP= Chronic Low Back Pain; HC= Healthy Controls; ♂= male; ♀=female; TPD = Two-Point Discrimination; BID= Body 
Image Drawings; FreBAQ= Fremantle Back Awareness Questionnaire; ODI = Oswestry Disability Score; PT= Physiotherapy; SF-36 = 
36-Item Short Form Health Survey (SF-36); RMDQ = Roland Morris Disability Questionnaire; NRS = Numerical Rating scale; Back 
Pain Intensity (0-100); Data are presented as Mean (SD) unless otherwise stated. 
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Methodological quality evaluation of the studies 
Across all 10 included studies, four methodological quality evaluations concerning 
reliability and/or measurement error were undertaken and received a poor 
methodological quality rating. Sixteen methodological quality evaluations of known-
groups or convergent validity were conducted with one rated as good, eleven as fair 
and four as poor (see Table 4 and 53). 
  
                                            
3 Reprinted from the Journal of Clinical Epidemiology, 63, Mokkink LB, Terwee CB, Patrick DL, Alonso 
J, Stratford PW, Knol DL, Bouter LM, de Vet HCW., International consensus on taxonomy, 
terminology, and definitions of measurement properties: results of the COSMIN study, 737-745., 
Copyright (2010), with permission from Elsevier 
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Table 4: Methodological quality evaluation: Reliability and Measurement Error Studies 
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TPD CV  
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Luomajoki  Moseley ( 2011) fair good fair good excell. excell. good n.a. n.a. fair good 
Luomajoki et al (2008) fair good fair excell. good good good n.a. n.a. fair good 
Graphestesia KGV  
Wand et al (2010) fair good fair fair excell. excell. good n.a. n.a. fair excell. 
Laterality Judgement  KGV  
Linder et al (2015) fair good fair good fair good good n.a. n.a. excell. # excell. 
Bowering et al (2014) good excell. excell. excell. good excell. good n.a. n.a. excell. excell. 
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Bray and Moseley ( 2011) fair good fair fair excell. excell. good n.a. n.a. fair excell. 
Laterality Judgement  CV  
Stanton et al (2013) poor good fair poor excell. excell. good excell. fair poor excell. 
BIDs KGV  
Nishigami et al (2015) fair good fair good fair Good good n.a. n.a. fair excell. 
Moseley (2008) poor good good poor fair good good n.a. n.a. fair poor 
FreBaQ KGV  
Wand et al (2014) fair good fair excell. fair good good n.a. n.a. excell. excell. 
TPD = Two-Point Discrimination; KGV= Known-Groups Validity; MCT= Movement Control Test; CV=Convergent Validity; BID= Body Image Drawings; 
FreBaQ= Fremantle Back Awareness Questionnaire; excell.= excellent; n.a.= not applicable 
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Reviewer Agreement 
The inter-rater agreement for methodological quality between raters was good 
(Altman, 1991) (absolute agreement = 73%, Cohen’s Kappa к = 0.62 (95% CI 0.54, 
0.70). Initial disagreement was resolved by consensus (see supplementary data 
Appendix 3: Reviewer Agreement). 
 
Measurement properties 
Reliability and Measurement Error 
Studies were identified that investigated the reliability of laterality judgement and the 
FreBaQ. 
 
Laterality Judgement: reliability 
Two studies (Bray and Moseley, 2011, Linder et al., 2015) (CLBP = 10 and 
CLBP=25/22), both of poor methodological quality, investigated the reliability of 
laterality judgement. Intraclass correlation coefficients (ICCs) for response time and 
accuracy were provided (see supplementary data: Appendix 5). 
ICC values ranged from 0.51 to 0.91 for reaction time and from 0.69 to 0.92 for 
accuracy. Thus, the level of reliability could be considered acceptable for accuracy, 
but not for reaction time against the predefined acceptable level (ICC ≥0.70). 
As this body of evidence consisted of only poor quality studies, the evidence for the 
reliability of laterality judgement was classified as unknown.  
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Linder et al. (2015) investigated measurement error reporting the coefficients of 
variation (CV) for reaction time and accuracy of repeated measurements between 
time point one and two (CLBP= 25) and between time point two and three (CLBP= 
22). For reaction time, the CV reduced from 19.6 % to 6.2 % whilst for accuracy it 
remained stable at 6.46 % to 6.77%. Data on minimally important change (MIC) were 
not provided. As this body of evidence consists of only one poor methodological 
quality study, the evidence for the measurement error of laterality judgement was 
classified as unknown.  
Fremantle Back Awareness Questionnaire (FreBaQ): reliability 
One study (Wand et al., 2014b), of poor methodological quality (n=26), investigated 
the test-retest reliability of the FreBaQ over a period of one week in people with 
CLBP (see supplementary data: Appendix 8). The test-retest performance was ICC2.1 
(95% CI) =0.652(0.307-0.848) (Agreement) and ICC2.1 (95% CI)=0.667(0.317-0.857) 
(Consistency). This was below the COSMIN threshold of ≥0.70. 
However, as this body of evidence consists of only one poor quality study, the 
evidence for the test-retest reliability of the FreBaQ was classified as unknown.  
 
 
Known-Groups Validity 
Studies investigating the known-groups validity of TPD, graphaesthesia, laterality 
judgement, MCTs and the FreBaQ were found.  
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Two Point Discrimination (TPD): Known-Groups Validity 
Five studies (CLBP=129, HC=91) investigated the known-groups validity of TPD 
were found. Four were of fair quality (Loumajoki and Moseley, 2011, Nishigami et al., 
2015, Stanton et al., 2013, Wand et al., 2010) and one of poor methodological quality 
(Moseley, 2008) (see supplementary data: Appendix 4). Four of these studies were 
broadly consistent regarding their measurement protocol, in particular regarding the 
region of the lower back assessed and the horizontal TPD measurement approaches 
(Luomajoki and Moseley, 2011, Moseley, 2008, Stanton et al., 2013, Wand et al., 
2010). The other study used side-to-side difference of TPD threshold as the outcome 
measure (Nishigami et al., 2015) and categorised patients according to their 
perceived body image. Of the four comparable studies, three identified a statistically 
wider TPD threshold for people with CLBP whilst the one study of poor 
methodological quality noted no difference between patients and healthy controls. 
When the three fair quality studies were statistically pooled people with CLBP 
demonstrated a statistically wider TPD threshold of 16 mm than healthy people 
(figure 2). No evidence of heterogeneity was found when the data was statistically 
pooled (Higgins and Green, 2011). Thus, there was moderate evidence from three 
studies of fair methodological quality that TPD possesses known-groups validity. 
 
Figure 2:  Forest Plot comparing TPD regarding its known-groups validity to 
distinguish between people with CLBP and healthy controls 
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Legend: IV = inverse variance; CI= confidence interval. Note: only data from 
horizontal TPD measurements were included in this analysis, leaving out values from 
vertical measurements from Luomajoki and Moseley (2011). 
 
Nishigami et al. (2015) also reported a statistically significant difference between 
groups regarding the side-to-side differences of TPD thresholds (CLBP=42, HC=17). 
Thus, there is limited evidence from one study of fair methodological quality that TPD 
side-to-side difference possesses known-groups validity.  
 
Laterality Judgment: Known Groups Validity 
Three studies (Bowering et al., 2014, Bray and Moseley, 2011, Linder et al., 2015) 
(168=CLBP, 473=HC) assessed the known-groups validity of laterality judgement, 
two of fair (Bray and Moseley, 2011, Linder et al., 2015) and one (Bowering et al., 
2014) of good methodological quality (see supplementary data: Appendix 5). Two 
studies (Bowering et al., 2014, Bray and Moseley, 2011) found a significant 
difference regarding laterality judgement accuracy, but only one concerning reaction 
time (Bowering et al., 2014), between people with CLBP and healthy controls, whilst 
one study found neither a statistical difference for reaction time nor accuracy (Linder 
et al., 2015). When the three studies were quantitatively pooled, people with CLBP 
were, on average, 9% less accurate and 0.1 seconds slower than healthy controls, 
both statistically significant. (figure 3a and 3b). The level of heterogeneity was 
substantial with I2 values of 65% and 90% for reaction time and accuracy 
respectively,  therefore, the findings should  be interpreted cautiously (Higgins and 
Green, 2011). Hence, there was moderate evidence from one study of good and two 
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of fair methodological quality that demonstrated known-groups validity in laterality 
judgement accuracy and reaction time. 
 
Figure 3a: Forest Plot Laterality Judgement Reaction Time 
 
 
Figure 3b: Forest Plot Laterality Judgement Accuracy 
 
Legend: IV = inverse variance; CI= confidence interval. For Linder et al. (2015) 
combined data for left/right laterality judgements were used for quantitative pooling; 
for Bowering et al (2014) only the data from “current back pain” patients were used. 
The data from Bowering et al (2014) was calculated from a graph using the software 
DigitizeIt®. 
 
Movement Control Tests (MCTs): Known-Groups Validity 
Two studies of fair methodological quality (Luomajoki et al., 2008, Luomajoki and 
Moseley, 2011) (CLBP=91, HC=147) investigated the known-groups validity of MCTs 
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(see supplementary data: Appendix 6). Both studies independently, and when 
quantitatively pooled (figure 4), found a statistically poorer performance in the MCT 
performance by people with CLBP compared to healthy controls. The degree of 
heterogeneity was low and, likely, of no importance (Higgins and Green, 2011). Thus, 
there is moderate evidence from two studies of fair methodological quality that MCTs 
demonstrate known-groups validity.  
 
Figure 4:  Forest Plot comparing movement control tests regarding their known-
groups validity to distinguish between people with CLBP and healthy 
controls 
 
Legend: IV = inverse variance; CI= confidence interval 
 
Graphesthesia: Known-Groups Validity 
One study (Wand et al., 2010) (CLBP=19, HC=19) of fair methodological quality 
evaluated the known-groups validity of graphesthesia (see supplementary data: 
Appendix 7). Performance, as adjudged by letter recognition error rates, was poorer 
in patients (mean difference; 6.1, 95% CI: 1.3 to 11.0). Thus, there was limited 
evidence from one study of fair methodological quality that graphesthesia 
demonstrates known-groups validity. 
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FreBaQ: Known-Groups Validity 
One study, which investigated the FreBaQ reliability also (Wand et al., 2014b) looked 
at the FreBaQ known-groups validity (see supplementary data: Appendix 8). Due to 
the larger sample size gathered for this specific question (n=52 CLBP, n=52 HC) the 
study’s methodological quality was rated fair (see supplementary data: Appendix 8). 
Data were presented as medians and inter-quartile ranges. The FreBaQ score 
(median [range]) for the patient and control group was 11 [0-26] and 0 [0–6], 
respectively, indicating poorer performance by patients (p<0.05). Thus, there is 
limited evidence from one study of fair methodological quality that the FreBaQ 
demonstrates known-groups validity. 
 
Convergent Validity 
Studies that investigated the convergent validity of TPD, laterality judgement and BID 
were found. 
 
Two Point Discrimination and Laterality judgment: Convergent Validity 
One study (n=17) of poor methodological quality investigated the convergent validity 
of TPD against laterality judgement in people with CLBP (Stanton et al., 2013) (see 
supplementary data: Appendices 4 and 5). An increase in the TPD threshold by 1 
mm was associated with a decrease in accuracy of 0.6% (β= - 0.06, 95% CI: 0.80 to 
0.43). However, as this body of evidence consists of only one poor quality study, the 
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quality of evidence for convergent validity of TPD and laterality judgment was 
classified as unknown.
Two-Point Discrimination and Body Image Drawings: Convergent Validity 
Two studies, one of fair (Nishigami et al., 2015) (CLBP= 42) and one of poor 
methodological quality (Moseley, 2008) (CLBP=6) reported aspects of convergent 
validity for BIDs compared to TPD in a qualitative manner. Nishigami et al. (2015) 
displayed TPD values for participants with CLBP who drew either a normal, 
expanded or shrunken body image. These data suggested that TPD was 
increased in patients who reported an expanded BID. Similarly, Moseley 
(Moseley, 2008) reported an increase of the TPD threshold corresponding to the 
zone of the absence or disruption of the BIDs.  However, as neither study 
quantified the relationship between TPD and BIDs, no evidence statement can be 
drawn regarding the convergent validity of BIDs. 
 
Discussion 
The aim of this study was to systematically investigate the reliability and validity of 
SMIs in people with CLBP. Ten studies investigating the following six SMIs were 
included; TPD, laterality judgment, MCTs, BIDs, FreBaQ, and graphesthesia. The 
methodological quality ranged from poor to good with only one study rated good 
(Bowering et al., 2014). The SMIs with the strongest support in the literature were 
TPD, laterality judgment and MCTs. There was moderate evidence to support the 
known-groups validity of these three SMIs. However, in general, there was a lack of 
high-quality studies investigating the clinimetric properties of SMIs for people with 
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CLBP. Hence, data collected using these techniques should be interpreted 
cautiously. 
 
Only three studies assessed reliability comprising two SMIs, the FreBaQ and 
laterality judgement. All three studies were graded as methodologically poor, 
primarily due to small sample sizes. Thus, the level of evidence for the reliability 
and/or measurement error of FreBaQ and laterality judgement was unknown. For all 
other outcome measures, there were no studies to inform an evidence statement 
regarding reliability or measurement error. Regarding convergent validity, there were 
four poor quality studies, investigating the convergent validity of either TPD, laterality 
judgement or BIDs. Thus, the level of convergent validity for these SMIs was 
considered unknown, and for the other outcome measures, there were no studies to 
inform an evidence statement. The state of the evidence only allowed for statements 
to be made with respect to the known-groups validity of the SMIs. 
 
TPD, laterality judgement and MCTs demonstrated the strongest evidence of known-
groups validity. Regarding TPD, our meta-analysis demonstrated a mean difference 
between healthy controls and people with CLBP of 16mm. This is broadly in keeping 
with a previous meta-analysis by Catley et al. (2014)  which compared TPD 
performance between healthy controls and people with CLBP reporting a mean 
difference of 11.7mm (95% CI:5.5 mm to 17.8 mm). The differences between our 
results and those of Catley et al. (21) are explained by the exclusion of the vertical 
TPD measurements from Luomajoki and Moseley (Loumajoki and Moseley, 2011) 
from the present meta-analysis and by the exclusion of the results from Moseley et 
al. (2008) as this study was rated of poor methodological quality in our review. Meta-
analysis for laterality judgement and MCTs demonstrated evidence for known-groups 
 38 
 
validity of both outcome measures. However, there are no previous meta-analyses 
with which to compare our findings.  
 
There was less evidence regarding graphesthesia, the FreBAQ and BIDs. One study 
of fair methodological quality implied a degree of known-groups validity for 
graphesthesia which was in line with results from studies investigating this technique 
in other clinical conditions, such as Parkinson disease (Jobst et al., 1997) and 
corticobasal degeneration (Drago et al., 2010). The results from one study of fair 
methodological quality demonstrated a degree of known-groups validity for the 
FreBaQ. A further study (Wand et al., 2016), published after the search cut-off date 
for the present review, investigated the psychometric properties of the FreBAQ by 
means of a Rasch analysis in 255 people with CLBP demonstrating adequate 
internal consistency with a person reliability index of 0.74 and a Cronbach’s Alpha 
Value of 0.80. As adequate internal consistency is an essential prerequisite for 
questionnaires which intend to measure a single underlying construct by multiple 
items (Terwee et al., 2007), the results provide a basis for further psychometric 
evaluation. There was very limited evidence upon which to make any 
recommendations regarding the use of BIDs in people with CLBP.  
 
Review limitations 
The search was restricted to full peer-reviewed published articles to enhance quality 
control, thus relevant conference papers/grey literature may have been excluded. 
Only one author undertook the screening and selection process increasing the risk of 
inadvertently excluding relevant studies. Additionally, only one reviewer extracted the 
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data from the included studies, which increases the risk of errors in the extraction 
process. 
There were variations in the data collection protocols reported in the reviewed 
studies. In some cases, the variations were quite marked. For example, Nishigami et 
al. (2015) measured TPD performance as side-to-side differences, which was very 
different to the TPD protocols used in the other included studies. However, the 
protocol differences between the other studies were more subtle (see supplementary 
data: Appendix 2). These variations in data collection protocols may have reduced 
the comparability of the studies. In addition, the studies included in this review tended 
to have small sample sizes, which can lead to over-inflated effect sizes. This may 
have influenced the results of our meta-analyses.  
The level of heterogeneity was substantial when the studies for laterality judgment 
were pooled for both reaction time and accuracy, thus these meta-analyses should 
be interpreted cautiously. 
 A key issue affecting the strengths of recommendations which can be drawn from 
this systematic review was the quality of included studies. Only one included study 
was rated as being of good methodological quality. In addition, the degree of 
reliability could not be established for any of the measures investigated in this review. 
Reliability is an important prerequisite of validity. Thus, the validity data presented 
should be interpreted cautiously.   There is a need for higher quality studies 
investigating the clinimetric properties of SMIs for people with CLBP, with particular 
attention to recruiting adequate sample sizes.  
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Conclusion 
There was a lack of high quality studies investigating the clinimetric properties of 
SMIs in people with CLBP. The methodological quality of the studies were 
predominately rated as poor or fair, with a small sample size frequently the reason for 
a low rating. The strongest body of evidence currently exists for TPD, laterality 
judgment and MCT with respect to known-groups validity. However, as the reliability 
of these measurement tools have yet to be established, this validity data should be 
interpreted cautiously. There is an urgent need to undertake high quality studies 
investigating the clinimetric performance of SMIs for people with CLBP in order to 
guide clinical and research practice. Given the state of the evidence, data collected 
using these SMIs should be treated cautiously.  
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Supplementary Data (e-Supplements): 
 
Appendix 1: Search Strategies for all databases 
Search Strategy Medline with search filter for measurement properties 
#1 "Sensory acuity"[tw] OR "Sensory perception"[tw] OR "sensory threshold"[tw] 
OR "Tactile acuity"[tw] OR "Tactile threshold"[tw] OR "tactile perception"[tw] OR 
"tactile discrimination"[tw] OR "tactual discrimination"[tw] OR "pressure sensitivity"[tw] 
OR "pressure sensibility"[tw] OR "proprioceptive"[tw] OR "acuity"[tw] OR "touch 
sensitivity"[tw] OR "tactile sensation*"[tw] OR "tactile sensitivity"[tw] OR "tactile 
sensibility"[tw] OR "depth-sense threshold"[tw] OR "perception threshold"[tw] OR 
"Discrimination sensation"[tw] OR "discriminative sensations"[tw] OR "Touch 
perception"[tw] OR "sensorimotor performance"[tw] OR "sensorimotor 
competence"[tw] OR "distorted body image"[tw] OR "Body schema"[tw] OR "physical 
self-awareness"[tw] OR "primary somatosensory cortex"[tw] OR "primary sensory 
cortex"[tw] OR "sensory-motor incongruence"[tw] OR "S1"[tw] OR "S1 
representation"[tw] OR "Cortical reorganisation"[tw] OR "Cortical reorganization"[tw] 
OR "Consciousness"[tw] OR Neuroimaging[tw] OR "Neuronal plasticity"[tw] OR 
"cortical body map"[tw] OR "Touch Perception"[MeSH Terms] OR 
"Touch/physiology"[MeSH Terms] OR "Recognition (Psychology)"[MeSH Terms] OR 
"Pain Perception"[MeSH Terms] OR "Discrimination Learning"[MeSH Terms] OR 
"Discrimination (Psychology)/physiology*"[MeSH Terms] OR 
"Perception/physiology"[MeSH Terms] OR "proprioception/physiology"[MeSH Terms] 
OR "Pain Threshold"[MeSH Terms] OR "Pattern Recognition, Physiological"[MeSH 
Terms] OR "Brain mapping"[MeSH Terms] 
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#2 back pain[tw] OR backache[tw] OR lumbago[tw] OR sciatic[tw] OR sciatica[tw] 
OR "low back disorder "[tw] OR "low back pain"[tw] OR "Chronic low back pain"[tw] 
OR "lower back pain"[tw] OR "non-specific low back pain"[tw] OR "NSCLBP"[tw] OR 
"back injury"[tw] OR "lumbar spine dysfunction"[tw] OR "Back Pain"[MeSH Terms] 
OR Sciatica[MeSH Terms] OR "Low Back Pain"[MeSH Terms] OR "Low Back 
Pain/physiopathology*"[MeSH Terms] 
#3  Sensorymotor*[tw] OR Sensorimotor*[tw] OR "Sensory-motor*"[tw] OR 
Sensomotor[tw] OR Sensomotoric[tw] OR "sensori-motor"[tw] OR "sensory-
perceptual-motor*"[tw] OR "sensory discrimination"[tw] OR "tactile stimulation"[tw] 
OR "Tactile assessments"[tw] OR "tactile perceptual tasks"[tw] OR "tactile tests"[tw] 
OR "sensory tests"[tw] OR "sensory testing"[tw] OR "somatosensory task"[tw] OR 
"somatosensory testing"[tw] OR "Test"[tw] OR "Testing"[tw] OR task[tw] OR 
"Somatosensory Cortex"[MeSH Terms] OR "Motor Cortex"[MeSH Terms] OR 
"Physical Stimulation"[MeSH Terms] OR "Two point discrimination"[tw] OR "Two-
point discrimination"[tw] OR "Two-point-discrimination"[tw] OR "two-point 
thresholds"[tw] OR "TPD threshold"[tw] OR "2-point discrimination"[tw] OR "2-PD"[tw] 
OR "TPD"[tw] OR "T.P.D"[tw] OR "discrimination threshold" OR Graphaestesia[tw] 
OR graphesthesia[tw] OR graphestesia[tw] OR "lumbopelvic motor control"[tw] OR 
"Movement Control"[tw] OR "Lumbopelvic control"[tw] OR "Movement test"[tw] OR 
"Motor Activity/physiology*"[MeSH Terms] OR "Lumbosacral Region"[MeSH Terms] 
OR "Motor Skills*"[MeSH Terms] OR "Movement/physiology"[MeSH Terms] OR 
"Movement Disorders"[MeSH Terms] OR "Body image drawing"[tw] OR "motor 
imagery"[tw] OR "motor imagery task"[tw] OR "Body schema"[tw] OR "body-
perception"[tw] OR "Body image assessment"[tw] OR "Body image perception"[tw] 
OR "body image"[MeSH Terms] OR "motor imagery"[tw] OR "left/right judgment"[tw] 
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OR "left/right judgement"[tw] OR "Recognition (Psychology)"[MeSH Terms] OR 
"Functional Laterality"[MeSH Terms] 
#4 instrumentation[sh] OR methods[sh] OR Validation Studies[pt] OR 
Comparative Study[pt] OR "psychometrics"[MeSH] OR psychometr*[tiab] OR 
clinimetr*[tw] OR clinometr*[tw] OR "outcome assessment (health care)"[MeSH] OR 
outcome assessment[tiab] OR outcome measure*[tw] OR "observer variation"[MeSH] 
OR observer variation[tiab] OR "Health Status Indicators"[MeSH] OR "reproducibility 
of results"[MeSH] OR repoducib*[tiab] OR "discriminant analysis"[MeSH] OR 
reliab*[tiab] OR unreliab*[tiab] OR valid*[tiab] OR coefficient[tiab] OR 
homogeneity[tiab] OR homogeneous[tiab] OR "internal consistency"[tiab] OR 
(cronbach*[tiab] AND (alpha[tiab] OR alphas[tiab])) OR (item[tiab] AND 
(correlation*[tiab] OR selection*[tiab] OR reduction*[tiab])) OR agreement[tiab] OR 
precision[tiab] OR imprecision[tiab] OR "precise values"[tiab] OR test-retest[tiab] OR 
(test[tiab] AND retest[tiab]) OR (reliab*[tiab] AND (test[tiab] OR retest[tiab])) OR 
stability[tiab] OR interrater[tiab] OR inter-rater[tiab] OR intrarater[tiab] OR intra-
rater[tiab] OR intertester[tiab] OR inter-tester[tiab] OR intratester[tiab] OR intra-
tester[tiab] OR interobserver[tiab] OR inter-observer[tiab] OR intraobserver[tiab] OR 
intra-observer[tiab] OR intertechnician[tiab] OR inter-technician[tiab] OR 
intratechnician[tiab] OR intra-technician[tiab] OR interexaminer[tiab] OR inter-
examiner[tiab] OR intraexaminer[tiab] OR intra-examiner[tiab] OR interassay[tiab] OR 
inter-assay[tiab] OR intraassay[tiab] OR intra-assay[tiab] OR interindividual[tiab] OR 
inter-individual[tiab] OR intraindividual[tiab] OR intra-individual[tiab] OR 
interparticipant[tiab] OR inter-participant[tiab] OR intraparticipant[tiab] OR intra-
participant[tiab] OR kappa[tiab] OR kappa's[tiab] OR kappas[tiab] OR repeatab*[tiab] 
OR ((replicab*[tiab] OR repeated[tiab]) AND (measure[tiab] OR measures[tiab] OR 
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findings[tiab] OR result[tiab] OR results[tiab] OR test[tiab] OR tests[tiab])) OR 
generaliza*[tiab] OR generalisa*[tiab] OR concordance[tiab] OR (intraclass[tiab] AND 
correlation*[tiab]) OR discriminative[tiab] OR "known group"[tiab] OR factor 
analysis[tiab] OR factor analyses[tiab] OR dimension*[tiab] OR subscale*[tiab] OR 
(multitrait[tiab] AND scaling[tiab] AND (analysis[tiab] OR analyses[tiab])) OR item 
discriminant[tiab] OR interscale correlation*[tiab] OR error[tiab] OR errors[tiab] OR 
"individual variability"[tiab] OR (variability[tiab] AND (analysis[tiab] OR values[tiab])) 
OR (uncertainty[tiab] AND (measurement[tiab] OR measuring[tiab])) OR "standard 
error of measurement"[tiab] OR sensitiv*[tiab] OR responsive*[tiab] OR 
((minimal[tiab] OR minimally[tiab] OR clinical[tiab] OR clinically[tiab]) AND 
(important[tiab] OR significant[tiab] OR detectable[tiab]) AND (change[tiab] OR 
difference[tiab])) OR (small*[tiab] AND (real[tiab] OR detectable[tiab]) AND 
(change[tiab] OR difference[tiab])) OR meaningful change[tiab] OR "ceiling 
effect"[tiab] OR "floor effect"[tiab] OR "Item response model"[tiab] OR IRT[tiab] OR 
Rasch[tiab] OR "Differential item functioning"[tiab] OR DIF[tiab] OR "computer 
adaptive testing"[tiab] OR "item bank"[tiab] OR "cross-cultural equivalence"[tiab] 
#5 #1 AND #2 AND #3 AND #4 
#6 #5 NOT  ("addresses"[pt] OR "biography"[pt] OR "case reports"[pt] OR 
"comment"[pt] OR "directory"[pt] OR "editorial"[pt] OR "festschrift"[pt] OR 
"interview"[pt] OR "lectures"[pt] OR "legal cases"[pt] OR "legislation"[pt] OR 
"letter"[pt] OR "news"[pt] OR "newspaper article"[pt] OR "patient education 
handout"[pt] OR "popular works"[pt] OR "congresses"[pt] OR "consensus 
development conference"[pt] OR "consensus development conference, nih"[pt] OR 
"practice guideline"[pt]) NOT ("animals"[MeSH Terms] NOT "humans"[MeSH Terms]) 
 
 51 
 
Search Strategy Embase  
#1 (Sensory acuity or Sensory perception or sensory threshold or Tactile acuity or 
Tactile threshold or tactile perception or tactile discrimination or tactual discrimination 
or pressure sensitivity or pressure sensibility or proprioceptive or acuity or touch 
sensitivity or tactile sensation$ or tactile sensitivity or tactile sensibility or depth-sense 
threshold or perception threshold or Discrimination sensation or discriminative 
sensations or Touch perception or sensorimotor performance or sensorimotor 
competence or distorted body image or Body schema or physical self-awareness or 
primary somatosensory cortex or primary sensory cortex or sensory-motor 
incongruence or S1 or S1 representation or Cortical reorganization or Cortical 
reorganisation or Neuroimaging or Neuronal plasticity or cortical body map).mp. or 
exp touch/ or exp recognition/ or exp nociception/ or exp proprioception/ or exp pain 
threshold/ or exp brain mapping/ or exp discrimination learning/ or exp perceptive 
threshold/ 
#2 (back pain or backache or lumbago or sciatic or sciatica or low back disorder 
or low back pain or chronic low back pain or lower back pain or non-specific low back 
pain or NSCLBP or back injury or lumbar spine dysfunction).mp. 
#3 (Sensorymotor* or Sensorimotor* or sensory-motor* or sensori-motor* or 
Sensomotor or Sensomotoric or sensory-perceptual-motor* or sensory discrimination 
or tactile stimulation or Tactile assessments or tactile perceptual tasks or tactile tests 
or sensory tests or sensory testing or somatosensory task or somatosensory testing 
or test or testing or task or Two point discrimination or two-point thresholds or TPD 
threshold or 2-point discrimination or 2-PD or TPD or "T.P.D" or discrimination 
threshold or graphaestesia or graphesthesia or graphestesia or lumbopelvic motor 
control or movement control or Lumbopelvic control or Movement test or 
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Lumbosacral Region or Body image drawing or motor imagery or motor imagery task 
or Body schema or body-perception or Body image assessment or Body image 
perception or "left/right judgment" or "left/right judgement").mp. or exp motor 
dysfunction/ or exp "movement (physiology)"/ or exp recognition/ or exp body image/ 
or exp somatosensory cortex/ or exp motor cortex/ or exp motor activity/ or exp motor 
performance/ 
#4 #1 AND #2 AND #3  
#5 4 NOT (editorial or letter or conference abstract or conference paper or 
conference proceeding or conference review).pt. not (exp animal/ not exp human/) 
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Search Strategy CINAHL 
S1 TX Sensory acuity OR TX Sensory perception OR TX sensory threshold OR 
TX Tactile acuity OR TX Tactile threshold OR TX tactile perception OR TX tactile 
discrimination OR TX tactual discrimination OR TX pressure sensitivity OR TX 
pressure sensibility OR TX proprioceptive OR TX acuity OR TX touch sensitivity OR 
TX tactile sensation* OR TX tactile sensitivity OR TX tactile sensibility OR TX depth-
sense threshold OR TX perception threshold OR TX Discrimination sensation OR TX 
discriminative sensations OR TX Touch perception OR TX sensorimotor performance 
OR TX sensorimotor competence OR TX distorted body image OR TX Body schema 
OR TX physical self-awareness OR TX primary somatosensory cortex OR TX 
primary sensory cortex OR TX sensory-motor incongruence OR TX "S1" OR TX "S1 
representation" OR TX Cortical reorganization OR TX Cortical reorganization OR TX 
Consciousness OR TX Neuroimaging OR TX Neuronal plasticity OR TX cortical body 
map OR MH "Touch/PH" OR MH "Recognition Psychology" OR MH "Pain+" OR MH 
"Perception+" OR MH "Perception/PH" OR MH "Proprioception+/PH" OR MH "Pain 
Threshold" OR MH "Brain Mapping" 
S2 TX back pain OR TX backache OR TX lumbago OR TX sciatic OR TX sciatica 
OR TX low back disorder OR TX low back pain OR TX Chronic low back pain OR TX 
lower back pain OR TX non-specific low back pain OR TX NSCLBP OR TX back 
injury OR TX lumbar spine dysfunction OR MH "Back Pain+" OR MH "Sciatica" OR 
MH "Low Back Pain" OR MH "Low Back Pain/PP" 
S3 TX Sensorymotor* OR TX Sensorimotor* OR TX Sensory-motor* OR TX 
Sensomotor OR TX Sensomotoric OR TX sensori-motor OR TX sensory-perceptual-
motor* OR TX sensory discrimination OR TX tactile stimulation OR TX Tactile 
assessments OR TX tactile perceptual tasks OR TX tactile tests OR TX sensory tests 
 54 
 
OR TX sensory testing OR TX somatosensory task OR TX somatosensory testing 
OR TX Test OR TX Testing OR TX task OR MH "Physical Stimulation+" OR TX Two 
point discrimination OR TX Two-point discrimination OR TX Two-point-discrimination 
OR TX two-point thresholds OR TX TPD threshold OR TX 2-point discrimination OR 
TX 2-PD OR TX TPD OR TX T.P.D OR TX discrimination threshold OR TX 
Graphaestesia OR TX graphesthesia OR TX graphestesia OR TX lumbopelvic motor 
control OR TX Movement Control OR TX Lumbopelvic control OR TX Movement test 
OR MH "Motor Activity+/PH" OR MH "Motor Skills+" OR MH "Movement+/PH" OR 
MH "Movement Disorders+" OR TX Body image drawing OR TX motor imagery OR 
TX motor imagery task OR TX Body schema OR TX body-perception OR TX Body 
image assessment OR TX Body image perception OR MH "Recognition Psychology" 
OR MH "Body Image+" OR TX motor imagery OR TX left/right judgment OR TX 
left/right judgement 
S4 S1 AND S2 AND S3  
S5 S4 NOT (PT biography OR PT case study OR PT commentary OR PT 
directories OR PT editorial OR PT interview OR PT legal case OR PT letter OR PT 
consumer/patient teaching materials OR PT practice guidelines) NOT ((MH 
"Animals+") NOT (MH "Human")) 
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Search Strategy CENTRAL 
#1 "Sensory acuity" OR "Sensory perception" OR "sensory threshold" OR "Tactile 
acuity" OR "Tactile threshold" OR "tactile perception" OR "tactile discrimination" OR 
"tactual discrimination" OR "pressure sensitivity" OR "pressure sensibility" OR 
proprioceptive OR acuity OR "touch sensitivity" OR "tactile sensation*" OR "tactile 
sensitivity" OR "tactile sensibility" OR "depth-sense threshold" OR "perception 
threshold" OR "Discrimination sensation" OR "discriminative sensations" OR "Touch 
perception" OR "sensorimotor performance" OR "sensorimotor competence" OR 
"distorted body image" OR "Body schema" OR "physical self-awareness" OR 
"primary somatosensory cortex" OR "primary sensory cortex" OR "sensory-motor 
incongruence" OR "S1" OR "S1 representation" OR "Cortical reorganisation" OR 
"Cortical reorganization" OR Consciousness OR Neuroimaging OR "Neuronal 
plasticity" OR "cortical body map"  
#2  MeSH descriptor: [Touch Perception] explode all trees 
#3 MeSH descriptor: [Touch] explode all trees and with qualifier(s): [Physiology - 
PH] 
#4 MeSH descriptor: [Recognition (Psychology)] explode all trees 
#5 MeSH descriptor: [Pain Perception] explode all trees 
#6 MeSH descriptor: [Discrimination Learning] explode all trees 
#7 MeSH descriptor: [Discrimination (Psychology)] explode all trees and with 
qualifier(s): [Physiology - PH] 
#8 MeSH descriptor: [Perception] explode all trees and with qualifier(s): 
[Physiology - PH] 
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#9 MeSH descriptor: [Proprioception] explode all trees and with qualifier(s): 
[Physiology - PH] 
#10 MeSH descriptor: [Pain Threshold] explode all trees 
#11 MeSH descriptor: [Pattern Recognition, Physiological] explode all trees 
#12 MeSH descriptor: [Brain Mapping] explode all trees 
#13 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 
OR #12  
#14 "back pain" OR backache OR lumbago OR sciatic OR sciatica OR "low back 
disorder" OR "low back pain" OR "Chronic low back pain" OR "lower back pain" OR 
"non-specific low back pain" OR "NSCLBP" OR "back injury" OR "lumbar spine 
dysfunction"  
#15 MeSH descriptor: [Back Pain] explode all trees 
#16 MeSH descriptor: [Sciatica] explode all trees 
#17 MeSH descriptor: [Low Back Pain] explode all trees 
#18 MeSH descriptor: [Low Back Pain] explode all trees and with qualifier(s): 
[Physiopathology - PP] 
#19 #14 OR #15 OR #16 OR #17 OR #18 
#20 Sensorymotor* OR Sensorimotor* OR "Sensory-motor*" OR Sensomotor OR 
Sensomotoric OR "sensori-motor" OR "sensory-perceptual-motor*" OR "sensory 
discrimination" OR "tactile stimulation" OR "Tactile assessments" OR "tactile 
perceptual tasks" OR "tactile tests" OR "sensory tests" OR "sensory testing" OR 
"somatosensory task" OR "somatosensory testing" OR "Test" OR "Testing" OR task 
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OR "Two point discrimination" OR "Two-point discrimination" OR "Two-point-
discrimination" OR "two-point thresholds" OR "TPD threshold" OR "2-point 
discrimination" OR "2-PD" OR "TPD" OR "T.P.D" OR "discrimination threshold" OR 
Graphaestesia OR graphesthesia OR graphestesia OR "lumbopelvic motor control" 
OR "Movement Control" OR "Lumbopelvic control" OR "Movement test" OR "Body 
image drawing" OR "motor imagery" OR "motor imagery task" OR "Body schema" 
OR "body-perception" OR "Body image assessment" OR "Body image perception" 
OR "motor imagery" OR "left/right judgment" OR "left/right judgement"  
#21 MeSH descriptor: [Somatosensory Cortex] explode all trees 
#22 MeSH descriptor: [Motor Cortex] explode all trees 
#23 MeSH descriptor: [Physical Stimulation] explode all trees 
#24 MeSH descriptor: [Motor Activity] explode all trees and with qualifier(s): 
[Physiology - PH] 
#25 MeSH descriptor: [Lumbosacral region] explode all trees 
#26 MeSH descriptor: [Motor Skills] explode all trees 
#27 MeSH descriptor: [Movement Disorders] explode all trees 
#28 MeSH descriptor: [Body Image] explode all trees 
#29 MeSH descriptor: [Functional Laterality] explode all trees 
#30 MeSH descriptor: [Movement] explode all trees and with qualifier(s): 
[Physiology - PH] 
#31 MeSH descriptor: [Recognition (Psychology)] explode all trees 
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#32 #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 OR #27 OR #28 OR 
#29 OR #30 OR #31  
#33 #13 AND #19 AND #32 
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Appendix 2: Individual study data collection protocols (adapted from (Pin, 2014) 
Author 
(Year) 
a. Instrument 
b. Assessor (Profession) 
c. Equipment 
d. Rehearsal 
Patient position Instructions/ 
Feedback 
Administration 
Linder et al 
(2015) 
a. Laterality Judgement 
b. PT 
c. Program: 
 Recognise OnlineTM –
Difficulty setting “Vanilla” – 
Images displayed against 
plain background, randomly 
rotated at 0°, 90° or 180° to 
either the left or right 
distributed equally regarding 
laterality and rotation. 
d. 2 instructional images before 
each part of testing 
seated 
comfortably with 
elbows at 90°, 
palms facing 
downwards, either 
left or right hand 
used on keys A 
and D or left/right 
arrows  
Instructions: 
Session 1: 
Oral instruction by PT 
Session 2 and 3: 
Written instructions 
Feedback: 
NA  
60 trunk images; Participants 
should determine, whether the 
depicted trunk was moved, 
laterally, flexed or rotated to the left 
or right.  
After 5 s new image if no selection 
was made.   
Bowering 
et al 
(2014) 
a. Laterality Judgement 
b. NA 
c. Program: Recognise 
OnlineTM – Images of the 
back and control images, 
which contained the back 
with another body part; 
“Neutral Images” - displayed 
against plain background, 
randomly rotated at +90°, -
90° or 180° to either the left 
or right, distributed equally 
Seated on a 
comfortable chair 
in front of the 
computer; hand 
on keys A and D 
Instructions: 
Written instructions 
Feedback: 
Not provided during task 
40 images; 
2 identical testing blocks with 2 
minute break between; after 8 s a 
new image was presented if no 
selection was made.   
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Author 
(Year) 
a. Instrument 
b. Assessor (Profession) 
c. Equipment 
d. Rehearsal 
Patient position Instructions/ 
Feedback 
Administration 
regarding laterality and 
rotation. 
d. 2 instructional images 
displaying a left or right 
hand; Participants had to 
press the “a” key for left and 
“d” for right 
Bray and 
Moseley 
(2011) 
a. Laterality Judgement 
b. NA 
c. Program: RecogniseTM; 28 
photographs of a male 
model in various positions; 
trunk rotated right between 
5° and 90°; photographs 
were digitally mirrored to 
construct identical pictures 
of the same model in various 
degrees of left rotation ;56 
pictures integrated into 
RecogniseTM 
d. Each trial preceded by 
practice trial of 80 pictures  
 
Participants 
positioned 
themselves so 
that they were 
comfortable; 
Index and middle 
finger of the 
dominant hand 
placed on key “a” 
for left and “d” for 
right. 
NA 56 photographs randomly 
displayed; 40 images per trial;2 
blocks with 3minute break 
between; Participants had to sit 
quietly 
 
Stanton et 
al (2013) 
Laterality Judgement 
Data obtained from Bray and Moseley (2011) 
Nishigami 
et al 
(2015) 
a. TPD 
b. NA 
NA Subjects were instructed 
to say “one” when they 
perceived one point and 
Bilateral assessment; Caliper 
position: perpendicular with the 
spine, transverse process of the 
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Author 
(Year) 
a. Instrument 
b. Assessor (Profession) 
c. Equipment 
d. Rehearsal 
Patient position Instructions/ 
Feedback 
Administration 
c. Plastic ruler with 1 mm 
precision 
d. NA 
“two” when they perceived 
two. 
most severe pain level and same 
opposite level centered between 
the two tips of the caliper 
Pressure:  until first blanching of 
the skin; Testing Order: Ascending:  
Starting at 0 mm, 5 mm steps until 
subjects identified “2 points”; 
Descending: Starting from 10 cm; 
5 mm steps until subjects identified 
“1 point”; Repetitions: 2 ascending, 
2 descending tests; Values of 1 
ascending and descending run per 
side were averaged; Determination 
of TPD threshold: Side-to side-
difference: TPD value higher pain 
side – TPD value lower pain side 
Stanton et 
al (2013) 
a. TPD 
b. NA 
c. Plastic caliper ruler 
d. Sensory testing with 
monofilaments to assess 
potential hypoesthesia 
NA NA Bilateral assessment; 
Caliper position: horizontally on 
both sides of the back; between 
the first lumbar vertebra and iliac 
crest; Pressure: Supra-sensory 
threshold; non-noxious; Testing 
Order: Ascending: Starting from 10 
mm; 5 mm increments  
Descending: 
Starting from 100 mm, 5 mm 
increments; Repetitions: 1 
ascending, 1 descending test; 
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Author 
(Year) 
a. Instrument 
b. Assessor (Profession) 
c. Equipment 
d. Rehearsal 
Patient position Instructions/ 
Feedback 
Administration 
Determination of TPD threshold: 
Mean of ascending/descending 
test per side; Average of right and 
left mean actual TPD threshold  
Luomajoki 
et al 
(2011) 
a. TPD 
b. Physiotherapist 
c. Plastic caliper ruler 
d. NA 
NA NA Bilateral Assessment; 
Caliper position: Horizontally and 
vertically between the first lumbar 
vertebra and iliac crest; Pressure: 
NA; Testing Order: Ascending: 
Starting from 10 mm; 5 mm 
increments  Descending: Starting 
from 100 mm, 5 mm increments; 
Repetitions: 1 ascending, 1 
descending test; Catch trials to 
prevent guessing (expanding the 
calipers instead of contracting or 
vice versa); Determination of TPD 
threshold: Average of 
ascending/descending test 
Wand et al 
(2010) 
a. TPD 
b. NA 
c. Lafayette two-point 
aesthesiometer, (Lafayette 
Instruments, Lafayette, IN, 
USA), 1 mm precision 
d. NA 
Positioned 
comfortably in 
prone lying on an 
examination table 
with back 
exposed 
Pillow under 
stomach to flatten 
the lumbar spine 
Subjects were instructed 
to say ‘one’ when they felt 
one point and ‘two’ when 
they felt two points. 
Bilateral Assessment; Caliper 
position: Parallel to the spine;  L3 
transverse process in the centre of 
the caliper; Pressure: until first 
blanching of the skin; Testing 
Order: Ascending: Starting at 0 
mm, 2 mm steps until subjects 
identified “2 points”; Descending:  
Starting from  a start point “well 
 63 
 
Author 
(Year) 
a. Instrument 
b. Assessor (Profession) 
c. Equipment 
d. Rehearsal 
Patient position Instructions/ 
Feedback 
Administration 
and to 
standardized 
lumbar position. 
above the initial ascending 
threshold value” ; 2 mm steps until 
patients identified “1 point”; 
Repetitions: NA; Determination of 
TPD threshold: Testing continued 
around initial values using 
ascending and descending 
sequences until a consistent 
response was obtained; Catch 
trials used to prevent guessing 
Moseley 
(2008) 
a. TPD 
b. NA 
c. Mechanical caliper with 1mm 
precision 
d. NA 
prone Subjects were instructed 
to say ‘one’, when one 
point was felt, ‘two’, when 
two points were felt. 
Bilateral Assessment; caliper 
position: 16 levels from the fourth 
thoracic vertebra to the bottom of 
the gluteal folds; Medial point was 
1, 2, 3 cm from midline; Pressure: 
until first blanching of the skin; 
Testing Order: Ascending: 
Starting at 0 mm, gradually 
increasing until patients identified 
“2 points”; Descending: NA; Level 
was randomised and 
counterbalanced; side was 
alternated until 6 measures (3 
each side) were obtained; 
Repetitions: 3 measures per level 
and side; Determination of TPD 
threshold: Average of 1 ascending 
and descending series  
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Author 
(Year) 
a. Instrument 
b. Assessor (Profession) 
c. Equipment 
d. Rehearsal 
Patient position Instructions/ 
Feedback 
Administration 
Average of 3 measures per level 
and side were used for analysis  
 
Luomajoki 
et al 
(2008) 
a. MCT 
b. PTs, on average 7 years 
working experience; not 
blinded to subject’s group  
c. NA 
d. Subjects did not know the 
tests before  
Depending on test 
starting position; 
Subjects wore 
underwear to 
allow inspection 
of the entire 
spine, hips and 
lower extremities 
Verbal standardized 
instructions specified for 
each test; 
If the subject did not 
understand how to perform 
the test, the examiner 
explained and 
demonstrated it again;  
 
Testing order: Waiter’s bow, Pelvic 
Tilt, One leg stance, Single knee 
extension, Quadruped position:  
• Rocking backward 
• Rocking forward 
Prone lying active knee flexion; 
Repetitions: 3 trials permitted; 
Rating Protocol: Clear movement 
dysfunction was rated as “not 
correct” and scored “1”; correct 
movements were scored”0”; If the 
movement control improved by 
instruction and correction, it was 
considered not a relevant 
movement dysfunction. 
Luomajoki 
and 
Moseley 
(2011) 
a. TPD 
b. Trained PT 
c. NA 
d. NA 
Depending on test 
starting position; 
Subjects were given a 
picture in which a model 
demonstrated the target 
alignment of the pelvis and 
lumbar spine as a 
reference 
Testing Order: 
Battery of six tests, referencing 
Luomajoki et al (2008); 
Repetitions: 
NA; Reference to Luomajoki et al 
(2008); Rating Protocol: Scores 
ranging from 6-0; 6 demonstrated 
the poorest movement control 
performance 
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Author 
(Year) 
a. Instrument 
b. Assessor (Profession) 
c. Equipment 
d. Rehearsal 
Patient position Instructions/ 
Feedback 
Administration 
Wand et al 
(2010) 
a. Graphesthesia 
b. NA 
c. Blunt end of monofilament 
d. Subjects were first shown a 
wall chart o upper case 
alphabet; letters and were 
instructed that this would be 
the way the letters would be 
drawn. They were then 
shown a diagram of the 
lumbar spine depicting the 
orientation and location of 
the letters 
positioned 
comfortably in 
prone lying on an 
examination table 
with back 
exposed 
Pillow under 
stomach to flatten 
the lumbar spine 
and to 
standardised 
lumbar position. 
Subjects were asked to 
identify the letters drawn 
on the back 
Testing order: 
Letters were drawn on three sites 
centred on the tips of the L1, L3 
and L5 transverse processes; did 
not extend across the midline; the 
height of the letters was such that 
there was no overlap in the area of 
skin in which the letters were 
drawn between the 3 sites; 20 
random letters at each level of the 
3 sites; 3 sites were tested in 
random order; Error rate out of 60 
was calculated for each side of the 
back 
Moseley et 
al (2008) 
a. BID 
b. NA 
c. a line drawing  showing the 
posterior surface of the back 
with only the top and bottom 
of the picture drawn 
d. NA 
Subjects stood in 
front of a waist 
high bench 
‘Concentrate on your back. 
Add to this drawing by 
following the outline of 
your own back as you 
track it in your mind. 
Concentrate on where you 
feel your back to be. Also 
draw in the vertebra that 
you can feel. Do this 
without touching your 
back. Your drawing should 
relate to your own sense 
of your back. Don’t draw 
any part you can’t sense. 
On request after instruction 
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Author 
(Year) 
a. Instrument 
b. Assessor (Profession) 
c. Equipment 
d. Rehearsal 
Patient position Instructions/ 
Feedback 
Administration 
Do not draw what you 
think your back looks like – 
draw what it feels like.” 
Nishigami 
et al 
(2015) 
a. BID 
b. NA 
c. a line drawing  showing the 
posterior surface of the back 
with only the top and bottom 
of the picture drawn (acc. to 
Moseley et al (2008)) 
d. NA 
Subjects were 
asked to sit in a 
chair 
“Concentrate on your 
back. Add to this drawing 
by following the outline of 
your own back as you 
track it in your mind. 
Concentrate on where you 
feel your back to be. Also 
draw in the vertebra that 
you can feel. Do this 
without touching your 
back. Do not draw any part 
you cannot sense. Do not 
draw what you think your 
back looks like- draw what 
it feels like.” 
On request after instruction 
Wand et al 
(2014) 
a. FreBAQ 
b. NA 
c. NA 
d. NA 
NA Written instructions First test: On site; Second test: 
Take home copy; filled out and 
posted one week later 
Legend: NA = information not available; PT = physiotherapist; TPD= Two-Point Discrimination; MCT = Movement Control Test; BID= 
body image drawings; FreBAQ= Fremantle Back Awareness Questionnaire 
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Appendix 3:  Reviewer Agreement 
Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
TPD Known-
Groups 
Validity 
      
Luomajoki and 
Moseley (2011) 
1 2 2 1 2 
 2 2 1 0 1 
 3 1 2 1 2 
 4 3 3 1 3 
 5 3 3 1 3 
 6 2 2 0 2 
 7 n.a. † n.a. 1 n.a. 
 8 n.a. n.a. 1 n.a. 
 9 3 3 0 3 
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Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
 10 2 3 1 2 
      
Stanton et al 
(2013) 
1 2 2 1 2 
 2 1 1 1 1 
 3 1 1 1 1 
 4 3 2 0 2 
 5 3 2 0 2 
 6 2 2 1 2 
 7 n.a. n.a. 1 n.a. 
 8 n.a. n.a. 1 n.a. 
 9 0 1 0 1 
 10 3 3 1 3 
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Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
Nishigami et al 
(2015) 
1 2 2 1 2 
 2 1 1 1 1 
 3 2 2 1 2 
 4 3 1 0 1 
 5 3 2 0 2 
 6 2 2 1 2 
 7 n.a. n.a. 1 n.a. 
 8 n.a. n.a. 1 n.a. 
 9 1 1 1 1 
 10 3 3 1 3 
       
Moseley (2008) 1 2 2 1 2 
 2 2 2 1 2 
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Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
 3 0 0 1 0 
 4 2 1 1 1 
 5 3 2 0 2 
 6 2 2 1 2 
 7 n.a. n.a. 1 n.a. 
 8 n.a. n.a. 1 n.a. 
 9 1 1 1 1 
 10 2 0 0 0 
        
Wand et al 
(2010) 
1 2 2 1 2 
 2 3 1 0 1 
 3 1 1 1 1 
 4 1 3 0 3 
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Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
 5 3 3 1 3 
 6 2 2 1 2 
 7 n.a. n.a. 1 n.a. 
 8 n.a. n.a. 1 n.a. 
 9 3 1 0 1 
 10 3 3 0 3 
       
TPD 
Convergent 
Validity 
      
Luomajoki and 
Moseley (2011) 
1 2 2 1 2 
 2 2 1 0 1 
 3 2 2 1 2 
 4 3 3 1 3 
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Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
 5 3 3 1 3 
 6 2 2 1 2 
 7 3 2 0 3 
 8 1 1 1 1 
 9 3 1 0 1 
 10 2 3 0 2 
       
Stanton et al 
(2013) 
1 2 2 1 2 
 2 1 1 1 1 
 3 0 0 1 0 
 4 3 3 1 3 
 5 3 3 1 3 
 6 2 2 1 2 
 74 
 
Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
 7 3 3 1 3 
 8 1 1 1 1 
 9 0 1 0 0 
 10 3 3 1 3 
       
Wand et al 
(2010) 
1 2 2 1 2 
 2 3 1 0 1 
 3 0 0 1 0 
 4 1 3 0 3 
 5 3 3 1 3 
 6 2 2 1 2 
 7 3 3 1 3 
 8 1 0 0 0 
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Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
 9 3 1 0 1 
 10 3 3 1 3 
       
MCT  Known-
Groups 
Validity 
      
Luomajoki and 
Moseley (2011) 
1 2 2 1 2 
 2 2 1 0 1 
 3 1 2 0 2 
 4 3 3 1 3 
 5 3 3 1 3 
 6 2 2 1 2 
 7 n.a. n.a. 1 n.a. 
 8 n.a. n.a. 1 n.a. 
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Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
 9 3 1 0 1 
 10 2 3 0 2 
       
       
Luomajoki et al 
(2008) 
1 2 2 1 2 
 2 1 1 1 1 
 3 3 3 1 3 
 4 2 2 1 2 
 5 2 2 1 2 
 6 2 2 1 2 
 7 n.a. n.a. 1 n.a. 
 8 n.a. n.a. 1 n.a. 
 9 1 1 1 1 
 77 
 
Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
 10 3 2 0 2 
       
MCT 
Convergent 
Validity 
      
Luomajoki and 
Moseley (2011) 
1 2 2 1 2 
 2 2 1 0 1 
 3 2 2 1 2 
 4 3 3 1 3 
 5 3 3 1 3 
 6 2 2 1 2 
 7 3 2 0 3 
 8 1 1 1 1 
 9 3 1 0 1 
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Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
 10 2 3 0 2 
       
Graphesthesia 
Known-
Groups 
Validity 
      
Wand et al 
(2010) 
1 2 2 1 2 
 2 3 1 0 1 
 3 1 1 1 1 
 4 1 3 0 3 
 5 3 3 1 3 
 6 2 2 1 2 
 7 n.a. n.a. 1 n.a. 
 8 n.a. n.a. 1 n.a. 
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Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
 9 3 1 0 1 
 10 3 3 1 3 
       
Graphesthesia 
Convergent 
Validity  
      
Wand et al 
(2010) 
1 2 2 1 2 
 2 3 1 0 1 
 3 2 2 1 2 
 4 1 3 0 3 
 5 3 3 1 3 
 6 2 2 1 2 
 7 3 3 1 3 
 8 1 1 1 1 
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Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
 9 3 1 0 1 
 10 3 3 1 3 
       
Laterality 
Judgement 
Known- 
Groups 
Validity 
      
Stanton et  al 
(2013) 
1 2 2 1 2 
 2 1 1 1 1 
 3 0 0 1 0 
 4 3 3 1 3 
 5 3 3 1 3 
 6 2 2 1 2 
 7 n.a. n.a. 1 n.a. 
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Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
 8 n.a. n.a. 1 n.a. 
 9 0 1 0 0 
 10 3 3 1 3 
       
Bowering et al 
(2014) 
1 2 3 0 3 
 2 3 3 1 3 
 3 3 3 1 3 
 4 3 3 1 3 
 5 3 3 1 3 
 6 2 2 1 2 
 7 n.a. n.a. 1 n.a. 
 8 n.a. n.a. 1 n.a. 
 9 3 3 1 3 
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Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
 10 3 3 1 3 
       
Bray and 
Moseley (2011) 
1 2 2 1 2 
 2 2 1 0 1 
 3 0 1 0 1 
 4 3 3 1 3 
 5 3 3 1 3 
 6 2 2 1 2 
 7 n.a. n.a. 1 n.a. 
 8 n.a. n.a. 1 n.a. 
 9 1 1 1 1 
 10 3 3 1 3 
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Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
Linder et al 
(2015) 
1 2 2 1 2 
 2 1 1 1 1 
 3 1 2 0 2 
 4 1 1 1 1 
 5 2 2 1 2 
 6 2 2 1 2 
 7 n.a. n.a. 1 n.a. 
 8 n.a. n.a. 1 n.a. 
 9 3 3 1 3 
 10 3 3 1 3 
       
Laterality 
Judgement 
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Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
Convergent  
Validity 
Stanton et al 
(2013) 
1 2 2 1 2 
 2 1 1 1 0 
 3 0 0 1 0 
 4 3 3 1 3 
 5 3 3 1 3 
 6 2 2 1 2 
 7 3 3 1 3 
 8 1 1 1 1 
 9 0 1 0 0 
 10 3 3 1 3 
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Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
 
Laterality 
Judgement 
Reliability 
Linder et al 
(2015) 
1 2 2 1 2 
 2 1 1 1 1 
 3 1 0 0 0 
 4 3 3 1 3 
 5 2 3 0 3 
 6 3 3 1 3 
 7 2 1 0 2 
 8 3 3 1 3 
 9 0 1 0 1 
 10 3 1 0 1 
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Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
 11 3 2 0 3 
 12 n.a. n.a. 1 n.a. 
 13 n.a. n.a. 1 n.a. 
 14 n.a. n.a. 1 n.a. 
       
Bray and 
Moseley (2011) 
1 2 2 1 2 
 2 2 1 0 1 
 3 0 0 1 0 
 4 3 3 1 3 
 5 3 3 1 3 
 6 3 3 1 3 
 7 2 2 1 2 
 8 3 3 1 3 
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Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
 9 2 2 1 2 
 10 1 1 1 1 
 11 2 2 1 2 
 12 n.a. n.a. 1 n.a. 
 13 n.a. n.a. 1 n.a. 
 14 n.a. n.a. 1 n.a. 
       
Laterality 
Judgement 
Measurement 
Error  
      
Linder et al 
(2015) 
1 2 2 1 2 
 2 1 1 1 1 
 3 2 0 0 0 
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Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
 4 3 3 1 3 
 5 3 3 1 3 
 6 3 3 1 3 
 7 1 2 0 2 
 8 3 3 1 3 
 9 1 1 1 1 
 10 1 1 1 1 
 11 2 2 1 2 
       
BIDs Known 
Groups   
Validity 
      
Nishigami et al 
(2015) 
1 2 2 1 2 
 2 1 1 1 1 
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Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
 3 2 2 1 2 
 4 3 1 0 1 
 5 3 2 0 2 
 6 2 2 1 2 
 7 n.a. n.a. 1 n.a. 
 8 n.a. n.a. 1 n.a. 
 9 1 1 1 1 
 10 3 3 1 3 
       
Moseley (2008) 1 2 2 1 2 
 2 2 2 1 2 
 3 0 0 1 0 
 4 2 1 0 1 
 5 3 2 0 2 
 90 
 
Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
  6 2 2 1 2 
 7 n.a. n.a. 1 n.a. 
 8 n.a. n.a. 1 n.a. 
 9 1 1 1 1 
 10 2 0 0 0 
       
FreBaQ 
Known 
Groups 
Validity 
     
Wand et al 
(2014) 
1 2 2 1 2 
 2 1 1 1 1 
 3 3 3 1 3 
 4 1 1 1 1 
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Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
 5 2 2 1 2 
 6 2 2 1 3 
 7 n.a. n.a. 1 n.a. 
 8 n.a. n.a. 1 n.a. 
 9 3 3 1 3 
 10 3 3 1 3 
      
FreBaQ 
Reliability 
      
Wand et al 
(2014) 
1 2 2 1 2 
 2 1 1 1 1 
 3 0 0 1 0 
 4 3 3 1 3 
 5 2 2 1 2 
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Author (year) COSMIN 
Item 
Methodological 
Quality Rating  
Reviewer 1 
Methodological 
Quality Rating  
Reviewer 2 
Rater Agreement 
1=agreement 
0=disagreement 
Final Methodological 
Quality Rating 
(consensus) 
 6 3 3 1 3 
 7 0 2 0 0 
 8 3 3 1 3 
 9 1 1 1 1 
 10 3 1 0 1 
 11 3 3 1 3 
 12 n.a. n.a. 1 n.a. 
 13 n.a. n.a. 1 n.a. 
 14 n.a. n.a. 1 n.a. 
Legend: TPD= Two-Point Discrimination; n.a. = not applicable; MCT= Movement Control Test; BIDs=Body Image 
Drawing; FreBaQ=Fremantle Back Awareness Questionnaire; Reviewer 1=KE; Reviewer 2=CR; 
Coding methodological quality  rating: 0 = poor; 1=fair; 2=good; 3=excellent 
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Appendix 4: Summary of TPD measurement properties (known-groups and convergent validity) 
Author (Year) a) Instrument 
b) Design 
c) n 
Measurement Property Result Mean Difference 
(95%CI) 
[p-value] 
COSMIN  
Score 
  Mean (SD) [mm]   
  CLBP HC   
Luomajoki and Moseley 
(2011) 
a) TPD 
b) Known-Groups Validity 
c) CLBP = 45 
HC = 45 
61 (13) 44 (10) 17*  
(12.14 to 21.86) 
[p < 0.01] 
fair 
Stanton et al (2013) a) TPD 
b) Known-Groups Validity 
c) CLBP =17 
HC =18 
59.8 (11.7) 45.3 (5.1) 14.50  
(8.34 to 20.65) 
[p < 0.0001] 
fair 
 Related Construct   
a) TPD 
b) Convergent Validity 
c) CLBP = 17 
Laterality Reconstruction 
Accuracy (%): 
β (95%CI) 
-0.6 (-0.80 to -0.43) 
not stated poor 
  CLBP 
Mean (SD) [mm] 
HC 
Mean (SD) 
[mm] 
  
Moseley (2008) a) TPD 
b) Known-Groups Validity 
c) CLBP = 6 
    HC = 10 
48.83 (1.83) 47 (8) 1.83  
(-5.38 to 9.037 ) 
[p =  0.59] 
poor 
Wand et al (2010) a) TPD 
b) Known-Groups Validity 
62.0 (21.6) 44.2 (13.7) 17.80  
(5.90 to 29.70) 
[p =  0.0045] 
fair 
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Author (Year) a) Instrument 
b) Design 
c) n 
Measurement Property Result Mean Difference 
(95%CI) 
[p-value] 
COSMIN  
Score 
c) CLBP = 19 
    HC = 19 
Nishigami et al (2015) a) TPD  
(mean difference between 
sides) 
b) Known-Groups Validity 
c) CLBP = 42 
    HC = 17 
normal BI: 
4.5 (5.5) 
expanded BI: 
13.3 (6.8) 
shrink: 
9.4 (7.0) 
5.5 (3.8) CLBP normal BI - HC: 
-1.00  
(-4.27 to 2.27)  
[p =  0.54]   
CLBP expanded BI - 
HC: 
7.80  
(3.75 to 11.85) 
[p =   0.0005]   
shrink BI - HC: 
 3.90  
(-0.23  to 8.03) 
[p =  0.06] 
Fair 
TPD=Two-Point Discrimination; SD=Standard Deviation; 95%CI= 95%Confidence Interval; CLBP=Chronic Low Back Pain; 
HC=Healthy Controls; BI= Body Image;  
*Bold figures indicate statistically significant differences 
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Appendix 5: Summary of Laterality Judgement measurement properties (known-groups and convergent validity, reliability 
and measurement error) 
Author 
(Year) 
a) Instrument 
b) Design 
c) n 
Measurement Property Mean Difference (95%CI) 
[p-value] 
COSMIN  
Score 
  Result  
Mean (SD) 
  
  CLBP HC   
Linder et 
al (2015) 
a) Laterality 
Judgement 
b) Known-Groups 
Validity 
c) CLBP = 30 
HC = 30 
ACC Right Trunk 
Rotation Mean 
(SD): 
S1: 88.7 (8.0) 
S2: 90.5 (9.8) 
S3: 90.6 (8.3) 
ACC  Left Trunk 
Rotation Mean 
(SD): 
S1: 89.0 (9.1) 
S2: 89.1 (11.2) 
 S3: 92.7 (7.4) 
RT right Trunk 
Rotation Mean 
(SD): 
S1: 1.89 (0.37) 
 S2: 1.60 (0.34) 
S3: 1.57 (0.26) 
RT left Rotation 
Mean (SD): 
S1: 1.93 (0.43) 
ACC Right Trunk 
Rotation Mean 
(SD): 
S1: 87.8 (20.2) 
 S2: 87.9 (12.8) 
S3: 91.8 (6.6) 
ACC  Left Trunk 
Rotation Mean 
(SD): 
S1:86.0 (10.4) 
S2: 89.0 (11.4) 
S3: 90.4 (7.9) 
RT right Trunk 
Rotation Mean 
(SD): 
S1: 2.01 (0.52) 
S2: 1.80 (0.53) 
S3:1.54 (0.34)  
RT left Rotation 
Mean (SD): 
S1: 2.01 (0.55) 
ACC Right Trunk Rotation  
S1: 0.90  
(-3.84 to 5.64) 
[p=0.90] 
S2: 2.600  
(3.29 to 8.49) 
[p=0.38] 
S3: -1.20  
(-5.08 to 2.68) 
[p=0.54]  
ACC  Left Trunk Rotation: 
S1: 3.00  
(-2.05 to 8.05) 
[p=0.24]  
S2:  0.10  
(5.74 to 5.94)  
[p=0.97]  
 S3: 2.30  
(-1.66 to 6.26) 
[p=0.25]  
fair 
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Author 
(Year) 
a) Instrument 
b) Design 
c) n 
Measurement Property Mean Difference (95%CI) 
[p-value] 
COSMIN  
Score 
  Result  
Mean (SD) 
  
  CLBP HC   
S2:1.64 (0.40) 
 S3: 1.57 (0.33) 
S2: 1.72 (0.47) 
S3: 1.55 (0.42) 
RT right Trunk Rotation  
S1: -0.08  
( -0.34 to 0.176) 
[p= 0.53]   
 S2: -0.08  
(0.31 to 0.15) 
[p= 0.50]    
S3: 0.02  
(-0.18 to 0.22)  
[p= 0.84]  
RT left Rotation Mean : 
S1: -0.08   
(-0.34 to 0.18) 
[p= 0.53]  
S2:  -0.08  
(-0.31 to 0.15) 
[p= 0.48] 
 S3: 0.02  
( -0.18 to 0.22) 
[p= 0.84] 
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Author 
(Year) 
a) Instrument 
b) Design 
c) n 
Measurement Property Mean Difference (95%CI) 
[p-value] 
COSMIN  
Score 
  Result  
Mean (SD) 
  
  CLBP HC   
Bowering 
et al 
(2014)* 
a) Laterality 
Judgement 
b) Known-Groups 
Validity 
c) Current back pain 
= 117 
History of back 
pain = 
462 
HC = 429 
RT Trunk Rotation  
1.89 (0.19) 
 
ACC Trunk 
Rotation: 
76.5 (3.4) 
RT Trunk Rotation  
1.74 (0.07) 
 
ACC Trunk 
Rotation: 
85.9 (0.08) 
RT Trunk Rotation: 
0.14† (0.11 to 0.17) 
[p < 0.0001] 
 
ACC Trunk Rotation: 
 -9.40  
(-10.02 to -8.78) 
[p < 0.0001] 
good 
Bray and 
Moseley 
(2011) 
a) Laterality 
Judgement 
b) Known-Groups 
Validity 
c) CLBP = 21 
HC = 14 
RT Trunk Rotation  
2.4 (0.35) 
  
ACC Trunk 
Rotation 
bilateral pain: 53.4 
(19.55) 
unilateral pain: 
67.2 (15.27) 
RT Trunk 
Rotation: 
2.4 (0.33) 
 
ACC Trunk 
Rotation: 
87 (19.92) 
RT Trunk Rotation  
0 (-0.24 to 0.24) 
[p=0]  
ACC Trunk Rotation: 
bilateral pain - HC: 
 -33.60  
(-47.43 to -19.77) 
[p < 0.0001] 
unilateral pain - HC: 
-19.80  
( -31.91 to -7.69) 
[p = 0.0022] 
fair 
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Author 
(Year) 
a) Instrument 
b) Design 
c) n 
Measurement Property Mean Difference (95%CI) 
[p-value] 
COSMIN  
Score 
  Result  
Mean (SD) 
  
  CLBP HC   
  Related Construct   
 
Stanton  
 et al  
(2013) 
a) Laterality 
Judgement 
b) Convergent 
Validity 
c) CLBP = 17 
TPD: 
β (95%CI) 
-0.6 (-0.80 to -0.43) 
 
 
n.a. 
 
 
poor 
   Result Reliability (95%CI)  
Bray and 
Moseley 
(2011) 
a) Laterality 
Judgement 
b) Test-Retest 
Reliability:  
 Mean Time 
 interval  (Range) 
 [days]:  
 1 (1-7) 
c) CLBP = 10 
 
 
 
 
 
 
 
 
 RT Trunk Rotation:  
ICC2,1=  0.872  
(0.731 - 0.951) 
ACC Trunk Rotation: 
ICC2,1=  0.920  
(0.831 - 0.970) 
poor 
 99 
 
Author 
(Year) 
a) Instrument 
b) Design 
c) n 
Measurement Property Mean Difference (95%CI) 
[p-value] 
COSMIN  
Score 
  Result  
Mean (SD) 
  
  CLBP HC   
   Result Reliability (95%CI)  
Linder et 
al (2015) 
a) Laterality 
Judgement 
b) Test-Retest 
Reliability  
Mean Time 
interval 
(Range) [days]:  
Session 1 to 2: 
2.2 (2-5) 
Session 2-3: 
2.4 (1-11) 
c) Session 1 and 2: 
CLBP = 25 
Session 2 and 3: 
CLBP = 22 
 Session 1 to 2: 
RT Trunk Rotation:  
ICC2,1=  0.51  
(0.15 - 0.75) 
ACC Trunk Rotation: 
ICC2,1=  0.71 
(0.44 - 0.86) 
Session 2 to 3: 
RT Trunk Rotation:  
ICC2,1=  0.91  
(0.79 - 0.96) 
ACC Trunk Rotation: 
ICC2,1=  0.69  
(0.39 - 0.86) 
 
 
 
 
 
 
 
 
 
poor 
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Author 
(Year) 
a) Instrument 
b) Design 
c) n 
Measurement Property Mean Difference (95%CI) 
[p-value] 
COSMIN  
Score 
  Result  
Mean (SD) 
  
  CLBP HC   
   Coefficient of Variation (95%CI):  
Linder et 
al (2015) 
a) Laterality 
Judgement  
b) Measurement 
ErrorƗ  
c) CLBP =22 
 Session 1 to 2: 
RT Trunk Rotation:  
19.6  
(13.79-25.64) 
ACC Trunk Rotation: 
6.46  
(4.52-8.32) 
Session 2 to 3: 
RT Trunk Rotation:  
6.23  
(4.35-8.14) 
ACC Trunk Rotation: 
6.77  
(4.72-8.86) 
poor 
ACC= Accuracy; RT= Reaction Time; S1,S2, S3 = Session 1,2,3; SD=Standard Deviation; ICC2,1 = Intraclass Correlation Coefficient; 
two-way random model;  95%CI= 95%Confidence Interval; CLBP=Chronic Low Back Pain; HC=Healthy Controls; TPD= Two-Point 
Discrimination; n.a.= not applicable;*Data from Bowering et al (2014) were derived via DigitizeIt® and p-values were calculated 
online via GraphPad Quick Calcs software; ǂBold figures indicate statistically significant differences; Ɨ= minimal important change 
(MIC) data was not provide 
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Appendix 6: Summary of Movement Control Test known-groups validity 
Author  
(Year) 
a) Instrument 
b) Design 
c) n 
Measurement Property Result     
    Result  
Mean (SD) [0-6] 
Mean Difference 
(95%CI) 
[p-value] 
COSMIN  
Score 
    CLBP HC     
Luomajoki and 
Moseley (2011) 
a) Movement Control 
Test 
b) Known-Groups 
Validity 
c) CLBP =45 
HC = 45 
3 (1.1) 1 (1.3) 2.00*  
(1.50 to 2.50) 
[p < 0.0001]   
fair 
Luomajoki et al 
(2008) 
a) Movement Control 
Test 
b) Known-Groups 
Validity 
c) LBP =102 
CLBP=46 
HC = 102 
CLBP 
2.37 (1.34) 
HC 
0.75  (1.03) 
1.62  
(1.22 to 2.02) 
[p < 0.0001]  
fair 
SD= Standard Deviation; CLBP= chronic low back pain; HC= healthy controls; 95%CI = 95% Confidence Interval; [0-6] = six tests 
are included in the test battery, the higher the score the worse the test performance; 
*Bold figures indicate statistically significant differences 
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Appendix 7: Summary of Graphesthesia known-groups validity 
Author (Year) d) Instrument 
e) Design 
f) n 
Measurement Property Result     
    Result  
Mean (SD) [Error Rate] 
Mean Difference (95%CI) 
[p-value] 
COSMIN  
Score 
    CLBP HC     
Wand et al (2010) a) Graphesthesia 
b) Known-Groups Validity 
c) CLBP =19 
HC = 19 
25.5 (8.0) 19.3 (6.8) 6.1*  
(1.3 to 11.0) 
[p =  0.01]   
fair 
SD= Standard Deviation; 95%CI= 95% Confidence Interval; CLBP=Chronic low back pain; HC=Healthy Controls;  
*Bold figures indicate statistically significant differences 
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Appendix 8: Summary of FreBaQ known-groups validity and reliability 
Author (Year) a) Instrument 
b) Design 
c) n 
Measurement Property 
Result 
Mean Difference 
(95%CI) 
[p-value] 
COSMIN  
Score 
  Mean  [0-36] 
Median (Range)   
  
  CLBP HC   
Wand et al 
(2014) 
a) FreBAQ 
b) Known-Groups Validity 
c) CLBP =51 
HC = 51 
10.8 
11 (0-26) 
0.5 
0 (0-6) 
Mann-Whitney Test 
11* 
[p < 0.001]  
fair 
   Result Reliability (95%CI)  
Wand et al 
(2014) 
a) FreBAQ 
b) Test-Retest Reliability 
(Mean Time interval: 1 
week) 
c) CLBP =26 
  ICC2,1=  0.652   
(0.307-0.848)  
(Agreement) 
ICC2,1 = 0.667   
(0.317-0.857)  
(Consistency) 
poor 
FreBAQ = Fremantle Back Awareness Questionnaire; CLBP= Chronic low back pain; HC= Healthy Controls; ICC2.1= intra class 
correlation coefficient (two-way random effect model with single measures); MIC=minimal important change 
*Bold figures indicate statistically significant differences 
 
